Sector portfolio · VC firm · United States

DCVC's Biotech portfolio

DCVC has backed 26 Biotech startups in rounds we track, $3.2B between them, shown by the stage each has reached. The best-funded is Zymergen.

26startups backed
4stages
$3.2Braised between them
Series Abiggest stage

DCVC's whole portfolioDCVC's profile

Series A

13

Series B

7

Series C and later

4

Pre-seed and seed

2

Segment by segment

Series A

13 startups · $959M raised

  1. AbCelleraAbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.Canada$526M
  2. Newleos TherapeuticsNewleos Therapeutics is a clinical-stage neuroscience and biotechnology company based in Boston, Massachusetts.United States$94M
  3. Samsara EcoSamsara Eco is an Australian biotechnology and environmental-tech company based in Sydney, specializing in enzymatic recycling technology.Australia$67M
  4. Kanvas BiosciencesKanvas Biosciences is a biotechnology company based in Princeton, New Jersey, founded in 2020.United States$61M
  5. Solu TherapeuticsSolu Therapeutics is a Boston-based clinical-stage biotechnology company focused on developing precision medicines to target and eUnited States$41M
  6. MetabiotaMetabiota is a provider of field data and risk analytics solutions for organizations to mitigate infectious diseases.United States$35M
  7. GenEditGenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.United States$33M
  8. TranscripticTranscriptic is a robotic cloud laboratory for life science.United States$28M

Series B

7 startups · $576M raised

  1. Sidewinder TherapeuticsSidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.United States$137M
  2. Chroma MedicineChroma Medicine, founded in 2021 and based in Boston/Cambridge, Massachusetts, is a biotechnology company focused on developing epUnited States$135M
  3. Lucira HealthLucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.United States$95M
  4. RecursionRecursion provides analytic data tool solutions such as recursion analyzers, mortgage company data and data cloud.United States$81M
  5. EnliticEnlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.United States$62M
  6. EmpiricoEmpirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.United States$45M
  7. 33ScanUnited States$21M

Series C and later

4 startups · $1.5B raised

  1. ZymergenUnited States$874M
  2. Ginkgo BioworksZymergen is now a part of Ginkgo Bioworks!United States$444M
  3. PlexiumPlexium is a biotechnology company based in San Diego, California, founded in 2018.United States$88M
  4. Frontier MedicinesFrontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.United States$87M

Pre-seed and seed

2 startups · $186M raised

  1. PBProxima BioUnited States$178M
  2. MSMolecular StethoscopeUnited States$8.2M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names DCVC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioDCVC's AI portfolio49 startups · $6.6BSector portfolioDCVC's Big Data & Analytics portfolio26 startups · $1.7BSector portfolioDCVC's IT Services portfolio12 startups · $460MCo-investorsWho invests with DCVC334 co-investorsPortfolio mapDCVC portfolio map181 startups · $21BSector portfolioTechstars' AI portfolio336 startups · $4.9B

Raising from investors like DCVC?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps